 |
|
Increased risk of heart attack or stroke for patients who are resistant to aspirin
January 18, 2008Aspirin 'resistance' and risk of cardiovascular morbidity: Systematic review and meta-analysis
Being resistant to aspirin makes patients four times more likely to suffer a heart attack, stroke or even die from a pre-existing heart condition, according to a study published on bmj.com today.
The study relates to patients who are prescribed aspirin long term as a way of preventing clots from forming in the blood.
Patients who are labelled "aspirin resistant" have blood cells (platelets) that are not affected in the same way as those of patients who are responsive to the drug, ie people who are "aspirin sensitive."
There is currently no agreed method of accurately determining who is and isn't aspirin resistant and the reasons why someone might be aspirin resistant are currently a cause of controversy.
Relatively few studies have looked at whether aspirin resistance has any impact on clinical outcome so the Canadian authors carried out a review of all the available data to better understand the relationship between the two.
They identified 20 studies, involving 2,930 patients with cardiovascular disease, all of whom had been prescribed aspirin as a way of preventing clots from forming in the blood. 28% were classified as aspirin resistant.
They found that all aspirin resistant patients, regardless of their underlying clinical condition, were at greater risk of suffering a heart attack, stroke or even dying. In particular they found that 39% of aspirin resistant patients compared to 16% of aspirin sensitive patients suffered some sort of cardiovascular event.
They also found that taking other drugs to thin the blood, such as Clopidogrel or Tirofiban, did not provide any benefit to these patients.
The authors conclude that there needs to be further studies on aspirin resistance to identify the most useful test to determine the condition. They also say aspirin resistance: "is a biological entity that should be considered when recommending aspirin as antiplatelet therapy."
BMJ-British Medical Journal
Patients who are labelled "aspirin resistant" have blood cells (platelets) that are not affected in the same way as those of patients who are responsive to the drug, ie people who are "aspirin sensitive."
There is currently no agreed method of accurately determining who is and isn't aspirin resistant and the reasons why someone might be aspirin resistant are currently a cause of controversy.
Relatively few studies have looked at whether aspirin resistance has any impact on clinical outcome so the Canadian authors carried out a review of all the available data to better understand the relationship between the two.
They identified 20 studies, involving 2,930 patients with cardiovascular disease, all of whom had been prescribed aspirin as a way of preventing clots from forming in the blood. 28% were classified as aspirin resistant.
They found that all aspirin resistant patients, regardless of their underlying clinical condition, were at greater risk of suffering a heart attack, stroke or even dying. In particular they found that 39% of aspirin resistant patients compared to 16% of aspirin sensitive patients suffered some sort of cardiovascular event.
They also found that taking other drugs to thin the blood, such as Clopidogrel or Tirofiban, did not provide any benefit to these patients.
The authors conclude that there needs to be further studies on aspirin resistance to identify the most useful test to determine the condition. They also say aspirin resistance: "is a biological entity that should be considered when recommending aspirin as antiplatelet therapy."
BMJ-British Medical Journal
Aspirin Current Events and Aspirin News RSSEarly end to key study on benefits of niacin, a B vitamin, in keeping arteries open was premature
Heart experts at Johns Hopkins are calling premature the early halt of a study by researchers at Walter Reed Army Medical Center and Washington Hospital Center on the benefits of combining extended-release niacin, a B vitamin, with cholesterol-lowering statin medications to prevent blood vessel narrowing.
Common Pain Relievers May Dilute Power of Flu Shots
With flu vaccination season in full swing, research from the University of Rochester Medical Center cautions that use of many common pain killers - Advil, Tylenol, aspirin - at the time of injection may blunt the effect of the shot and have a negative effect on the immune system.
News brief: Effects of aspirin and folic acid on inflammation markers for colorectal adenomas
Unexpectedly, inflammation markers do not appear to be involved with the chemopreventative effect of aspirin on colorectal adenomas, according to a brief communication published online October 12 in the Journal of the National Cancer Institute.
Aspirin Misuse May Have Made 1918 Flu Pandemic Worse
The devastation of the 1918-1919 influenza pandemic is well known, but a new article suggests a surprising factor in the high death toll: the misuse of aspirin.
Cogent trial shows lack of adverse interaction between clopidogrel and stomach medicine
Results from a late breaking clinical trial called COGENT demonstrate that the combination of giving patients clopidogrel, a blood thinner commonly prescribed to patients with cardiovascular disease, and stomach medicines such as omeprazole, known as proton pump inhibitors (PPIs), did not lead to adverse events, as some prior studies had suggested.
Aspirin works for primary prevention in moderate and high risk diabetics
The beneficial effects of aspirin in primary prevention of cardiovascular events i.e. stroke, MI and cardiac death are known and generally accepted.
New strategies for reperfusion therapy
A new trial has begun in order to ascertain once and for all whether the best strategy for patients who cannot receive P-PCI is early fibrinolysis, together with mandated angiography.
Small peptide found to stop lung cancer tumor growth in mice
In new animal research done by investigators at Wake Forest University School of Medicine, scientists have discovered a treatment effective in mice at blocking the growth and shrinking the size of lung cancer tumors, one of the leading causes of cancer death in the world.
Genetic variation associated with poorer response, cardiovascular outcomes with use of clopidogrel
Patients with a certain genetic variation who received the antiplatelet drug clopidogrel had a decreased platelet response to treatment and among those who had percutaneous coronary intervention (procedures such as balloon angioplasty or stent placement used to open narrowed coronary arteries) had an increased risk of having a cardiovascular event in the following year than patients who did not have this variant, according to a study in the August 26 issue of JAMA.
Study reveals mounting evidence of fish oil's heart health benefits
There is mounting evidence that omega-3 fatty acids from fish or fish oil supplements not only help prevent cardiovascular diseases in healthy individuals, but also reduce the incidence of cardiac events and mortality in patients with existing heart disease.
More Aspirin Current Events and Aspirin News Articles
 |
Bayer Low Dose 81 mg Aspirin Regimen-400 Tablets by Bayer Safety Coated "Baby" Aspirin - Aspirin Regimen For Adult Use * Often Recommended as "Baby" Aspirin by Doctors for Adult Aspirin Regimen Use * Small, Easy-To-Swallow Tablets * Safety Coated for Added Stomach Protection * Aspiring Protects Your Heart by Keeping Your Blood Flowing Freely For the temporary relief of minor aches and pains or as recommended by your doctor. Because of its delayed action, this product will not provide fast relief of headaches or other symptoms needing immediate relief. Ask your doctor about other uses for Safety Coated 81 mg Aspirin. |
 |
Member's Mark - Aspirin 81 mg, Adult Low Strength, 500 Tablets, Compare to St. Joseph's by Sam's West, Inc. 500 tablets |
 |
Low Dose Aspirin (enteric coated) 81mg 500 Tablets by Life Extension Numerous studies document the multiple health benefits of daily low dose aspirin. Aspirin helps to maintain normal platelet aggregation in blood vessels and the production of prostaglandin E2 and possibly C-reactive protein. |
 |
Equate - Aspirin 325 mg, Original Strength, 500 Coated Tablets, Pain Reliever (Compare to Buyer) by Perrigo. |
 |
Bayer Aspirin Pain Reliever/ Fever Reducer, 300-Count Coated Tablets (Pack of 2) by Bayer Pain Reliever/Fever Reducer. Fast, safe pain relief Plus the life saving benefits of aspirin. Headaches; Everyday aches and pains. Doctor recommended for Aspirin Regimen Use. Aspirin is not appropriate for everyone, so be sure to talk to your doctor befor |
 |
KS Enteric Coated Aspirin 81 mg Tablets - Adult Low Strength Regimen - Compare to the Active Ingredients in Bayer Enteric Coated Low Strength Aspirin - 730 ct. by Kirkland Signature Read all instructions and warnings before taking this or any other medication. |
 |
Bayer Aspirin Pain Reliever/ Fever Reducer, Low Dose Safety Coated for Baby (81 mg), 200-Count Enteric Coated Tablets (Pack of 2) by Bayer It is most often used by patients who are taking aspirin on a regular basis under a doctor's supervision. This product contains one-quarter the medicine of a regular strength aspirin tablet allowing you to more conveniently take the dosage directed by you |
 |
Bayer Aspirin Pain Reliever/ Fever Reducer, Extra Strength PLUS, 50-Count Caplets (Pack of 4) by Bayer Aspirin PLUS a "Buffer" to guard against upset stomach, Use for the temporary relief of headache, muscle pain, toothache, pain and fever of colds, menstrual pain, minor pain of arthritis |
 |
Bayer Aspirin Pain Reliever/ Fever Reducer, Extra Strength Back & Body Pain, 100-Count Caplets (Pack of 2) by Bayer Fast, Safe Pain Relief. Safely relieves tough pain Coated for easier swallowing Ask you doctor about the benefits of other Bayer® Aspirin products |
 |
BOTTLED ASPIRIN 1000/BOTTLE by GERI-CARE PHARMACEUTICALS 5 grain USP aspirin. Low cost generic bottled pain relief. 1000 tablets per bottle. |
| © 2009 BrightSurf.com |